Introduction: Cardiac arrhythmias a clinical problem.- Electrophysiological basis of the arrhythmias.- Class I antiarrhythmic drugs (Na+ channel blockers).- Potassium-channel blockers.- Betablockers.- Modulation of calcium handling/Calcium-channel modulators.- Other antiarrhythmic drugs: Novel targets for AADs.- Non-antiarrhythmic drugs with antiarrhythmic effects.- Clinical management of the arrhythmias.
This volume reviews current and potential future therapies for arrhythmias. It is a highly practical guide for the use of pharmaceuticals in the management of the discipline, and has been written in a simple quick-access format.
Antiarrhythmic Drugs builds on the current understanding of pathophysiological mechanisms and insights gained from previous studies of therapeutic interventions. It is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis.
A Martinez Rubio, is Chief of Cardiology in the Univ. Hospital of Sabadell and professor of Medicine at the Univ. Autonoma of Barcelona, Spain
J Tamargo is professor of Pharmacology at the School of Medicine of the Univ. Complutense of Madrid, Spain
G. Andrei Dan is Prof of Medicine at the Carol Davila University of Medicine, chief of the Internal Medicine Clinic and of Cardiology Department, Colentina University Hospital, Bucharest, Romania, immediate past President of ISCP